Hints and tips:
Related Special Reports
...Joseph Dupont, then a vice-president at Alexion Pharmaceuticals, now owned by AstraZeneca, shared knowledge of an upcoming acquisition of Portola Pharmaceuticals with Shawn Cronin, a childhood friend and...
...Nicholas Malins-Smith Cambridge, UK...
...Britain after Brexit is edited by Gordon Smith. Premium subscribers can sign up here to have it delivered straight to their inbox every Thursday afternoon....
...“The drive to renegotiate agreements is not unique to Novavax but they are more pressed against a wall because of their difficult financial situation,” said Brendan Smith, analyst at Cowen, an investment...
...In 2019, Namal Nawana, an Australian who had worked in the US, quit as chief executive of Smith & Nephew because the UK medical devices company could not meet his pay demands....
...The US drugmaker has spent almost $30bn on acquisitions over the past two years, snapping up Arena Pharmaceuticals, Biohaven Pharmaceuticals, Global Blood Therapeutics, ReViral and Trillium Therapeutics....
...Smith has looked into one of the problems that has taken the shine off Paxlovid....
...The show’s editor is Jess Smith. Additional help by Peter Barber and Gavin Kallmann. The show’s theme song is by Metaphor Music. Topher Forhecz is the FT’s executive producer....
...It’s all very colourful though. 5) Fern Labs Inc ($1mn for 5 per cent stake) There’s a company called Fern Labs Inc based at 280 Smith St, Farmingdale, NY 11735, United States, roughly in the middle of...
...Its share price has languished since chief executive Alan Jope took over in 2019, and top-10 investor Terry Smith this week attacked the company as “labouring under the weight of a management which is obsessed...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Smith said: “All companies want to hold on to their innovation....
...Attendees include Disney’s chief executive Bob Chapek, Microsoft’s president Brad Smith and Business Roundtable head Joshua Bolten....
...FedEx, which has shipped about half of vaccine doses in the US, is struggling with record volumes, though Richard Smith, the company’s regional president for the Americas, told the FT the jab deliveries...
...Hempton, known for his bets against companies such as Valeant Pharmaceuticals and Wirecard, raised concerns about the level of insurance extended to Greensill by IAG, calling it “potentially a solvency risk...
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...“This system is not really good for anyone,” says one pharmaceutical company employee in Massachusetts....
FT tracker shows rapid growth in doses administered around world — but warnings come of long road ahead
...Hungary is the only EU member to have approved both the Chinese-made Sinopharm and Russian-made Sputnik V vaccines....
...He spotted the value in an unloved unit of just 25 people still working on inoculations, led by Gale Smith, now Novavax’s vice-president of vaccine development....
...Germany’s BioNTech and US pharmaceutical company Pfizer said doses of the vaccine would be delivered to the UK in the coming days after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA)...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...Gayle Smith, president of the ONE Campaign against global poverty, says a lack of global co-ordination threatens to prolong the pandemic....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
International Edition